ORCHPHARMA

Orchid Pharma Share PriceOrchid Pharma

₹390.00
3.1 (0.8%)
As on 30 March, 2023 | 19:02 BSE: 524372 NSE: ORCHPHARMA

Orchid Pharma Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Orchid Pharma

Start SIP

Orchid Pharma Share Price

  • Over 1 Month 0.09%
  • Over 3 Month 7.66%
  • Over 6 Month 22.45%
  • Over 1 Year 43.49%

Orchid Pharma Key Statistics

P/E Ratio -82
PEG Ratio -24.1
Market Cap Cr 1,592
Price to Book Ratio 2.5
EPS -1.3
Dividend 0
Relative Strength Index 47.44
Money Flow Index 26.99
MACD Signal 1.25
Average True Range 17.52

Orchid Pharma Investment Rating

  • Master Rating:
  • Orchid Pharma has an operating revenue of Rs. 634.13 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of -10% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 10% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -8% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 36 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Orchid Pharma Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 160165131180
Operating Expenses Qtr Cr 146147119151
Operating Profit Qtr Cr 14181229
Depreciation Qtr Cr 8182227
Interest Qtr Cr 8984
Tax Qtr Cr 0000
Net Profit Qtr Cr 7-3-14-2

Orchid Pharma Technicals

EMA & SMA

Current Price
₹390.
3.1 (0.8%)
  • Bullish Moving Average
  • ___
  • 6
  • Bearish Moving Average
  • ___
  • 10
  • 20 Day
  • 394.21
  • 50 Day
  • 390.12
  • 100 Day
  • 381.09
  • 200 Day
  • 375.86
  • 20 Day
  • 394.9
  • 50 Day
  • 387.09
  • 100 Day
  • 387.2
  • 200 Day
  • 353.47

Orchid Pharma Resistance and Support

PIVOT
₹386.6
Resistance
First Resistance 398.2
Second Resistance 409.5
Third Resistance 421.1
RSI 47.44
MFI 26.99
MACD Single Line 1.25
MACD -0.55
Support
First Resistance 375.3
Second Resistance 363.7
Third Resistance 352.4

Orchid Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,650 165,000 100
Week 1,999 199,920 100
1 Month 4,443 444,348 100
6 Month 9,887 988,654 100

Orchid Pharma Result Highlights

Orchid Pharma Synopsis

NSE-Medical-Diversified

Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 556.97 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2022. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.
Market Cap 1,591
Sales 636
Shares in Float 0.41
No of funds 22
Yield
Book Value 2.35
U/D Vol ratio 1.3
LTDebt / Equity 31
Alpha 0.21
Beta 0.75

Orchid Pharma

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 89.96%89.96%89.96%
Mutual Funds 2.45%2.45%2.45%
Insurance Companies
Foreign Portfolio Investors 0.86%1.37%1.48%
Financial Institutions/ Banks 0.25%0.04%0.52%
Individual Investors 3.43%3.61%3.69%
Others 3.05%2.57%1.9%

Orchid Pharma Management

Name Designation
Mr. Ram Gopal Agarwal Chairman & Non-Exe.Director
Mr. Manish Dhanuka Managing Director
Mr. Mridul Dhanuka Whole Time Director
Mr. Arun Kumar Dhanuka Non Executive Director
Mrs. Tanu Singla Independent Director
Dr. Dharam Vir Independent Director
Mr. Manoj Kumar Goyal Independent Director
Mr. Mudit Tandon Independent Director

Orchid Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Orchid Pharma MF Shareholding

Name Amount(cr)
Nippon India Pharma Fund - Growth 4268

Orchid Pharma FAQs

What is Share Price of Orchid Pharma ?

Orchid Pharma share price is ₹390 As on 30 March, 2023 | 18:48

What is the Market Cap of Orchid Pharma ?

The Market Cap of Orchid Pharma is ₹1591.8 Cr As on 30 March, 2023 | 18:48

What is the P/E ratio of Orchid Pharma ?

The P/E ratio of Orchid Pharma is -82 As on 30 March, 2023 | 18:48

What is the PB ratio of Orchid Pharma ?

The PB ratio of Orchid Pharma is 2.5 As on 30 March, 2023 | 18:48

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number